<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04325984</url>
  </required_header>
  <id_info>
    <org_study_id>173_2018_DexaPOP</org_study_id>
    <nct_id>NCT04325984</nct_id>
  </id_info>
  <brief_title>Role of Dexamethasone in Multimodal Analgesia for Postoperative Pain in Thoracic Surgery</brief_title>
  <official_title>Ruolo Del Desametasone Per il Controllo Multimodale Del Dolore Postoperatorio in Chirurgia Toracica</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Trieste</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Trieste</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the analgesic properties of dexamethasone and to quantify
      the possible associated postoperative complications, such as wound infections and
      hyperglycaemia, in patients who underwent lobectomy, segmentectomy or atypical resection
      surgery with a mini-thoracotomy approach or video-assisted thoracoscopic surgery (VATS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We designed an observational study, aimed to evaluate the possible reduction in morphine
      consumption in thoracic patients, who were administered dexamethasone compared to who didn't
      received the drug.

      The research wants to assess the presence of additional analgesic properties, besides the
      well known antiemetic effect, in the intraoperative administration of dexamethasone, and the
      possible postoperative complications, such as wound infections and hyperglycaemia.

      The rational is to ameliorate the anaesthesiological management, in particular with a view to
      a opioid-sparing analgesia in thoracic patients.

      To do so, we enrolled thoracic patients, who underwent elective lobectomy, segmentectomy or
      atypical resection surgery with a mini-thoracotomy approach or video-assisted thoracoscopic
      surgery (VATS).

      We selected two groups: one in which patients were administered dexamethasone 8 mg at the
      moment of induction, and the other one in which patients didn't received dexamethasone, but
      ondansetron 4 mg at the end of surgery. Both groups received other antiemetic drugs based on
      Apfel score and multimodal analgesia, comprising loco-regional analgesia, opioids and other
      analgesic drugs administration.

      The we checked morphine consumption and Numerical Rating Scale (NRS) values for pain in the
      first 24 hours after surgery.

      Moreover we evaluate Post-Operative Nausea and Vomiting (PONV), intra- and post-operative
      blood glucose levels and wound infection.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 29, 2017</start_date>
  <completion_date type="Actual">March 6, 2019</completion_date>
  <primary_completion_date type="Actual">March 6, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine consumption</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Morphine dose, in milligrams, administered in the 24 hours after the surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Static and dynamic Numeric Rating Scale (NRS)</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Evaluation of Numeric Rating Scale (NRS) for static and dynamic pain; the NRS uses scores from 0 (no pain) to 10 (worst possible pain)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Glycemic changes</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Evaluation of intraoperative and postoperative blood glucose levels</description>
  </other_outcome>
  <other_outcome>
    <measure>Surgical wound infection</measure>
    <time_frame>At hospital discharge/ at first medical check if discharge was earlier than 7 days</time_frame>
    <description>Evaluation of infectious complication after surgery: assessment of the presence of signs and symptoms of infection of the surgical wound</description>
  </other_outcome>
  <other_outcome>
    <measure>Postoperative Nausea and Vomiting (PONV)</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Evaluation of development of postoperative nausea or vomiting, reporting the presence of episodes of nausea or vomiting in the 24 hours after the surgery</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">62</enrollment>
  <condition>Dexamethasone Adverse Reaction</condition>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Thoracic Procedure Complication</condition>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Dexamethasone group</arm_group_label>
    <description>Group of patients receiving dexamethasone 8 mg as part of the multimodal analgesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Group of patients receiving multimodal analgesia, not comprising dexamethasone; moreover, ondansetron 4 mg is administered for the control of PONV.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>To the Dexamethasone group, at the moment of the induction of anaesthesia, dexamethasone 8 mg is administered.</description>
    <arm_group_label>Dexamethasone group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted at our surgical center who underwent elective lobectomy, segmentectomy or
        atypical resection surgery with a mini-thoracotomy approach or VATS.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &lt; 30 kg/m2

          -  ASA I-III

          -  Lobectomy, segmentectomy or atypical resection surgery with a mini-thoracotomy
             approach or VATS

        Exclusion Criteria:

          -  Refusal by the patient to participate or patient unable to express his own consent

          -  Chronic therapy with medium-high doses of corticosteroids

          -  Chronic therapy with opioids

          -  METS â‰¤ 4, defining an overall decreased cardiovascular fitness

          -  Urgent or emergency surgery

          -  Allergy to the active ingredient of the drug used

          -  Kidney failure at stage III or more

          -  Liver failure

          -  Pregnancy

          -  Drug addiction, patients with a history of drug abuse

          -  Corrected Qt interval (QTc) &gt; 0,45 for males and 0,47 for women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Umberto Lucangelo, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Trieste</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marzia Umari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Trieste</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cattinara Hospital</name>
      <address>
        <city>Trieste</city>
        <zip>34149</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=Wenk+M%2C+Schug+SA.+Perioperative+pain+management+after+thoracotomy.+Curr+Opin+Anaesthesiol.+2011+Feb%3B24(1)%3A8%E2%80%9312.</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=Doan+LV%2C+Augustus+J%2C+Androphy+R%2C+Schechter+D%2C+Gharibo+C.+Mitigating+the+impact+of+acute+and+chronic+post-thoracotomy+pain.+J+Cardiothorac+Vasc+Anesth.+2014+Aug%3B28(4)%3A1048%E2%80%9356.</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=Henzi+I%2C+Walder+B%2C+Tram%C3%A8r+MR.+Dexamethasone+for+the+prevention+of+postoperative+nausea+and+vomiting%3A+a+quantitative+systematic+review.+Anesth+Analg.+2000+Jan%3B90(1)%3A186%E2%80%9394.</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=Waldron+NH%2C+Jones+CA%2C+Gan+TJ%2C+Allen+TK%2C+Habib+AS.+Impact+of+perioperative+dexamethasone+on+postoperative+analgesia+and+side-effects%3A+systematic+review+and+meta-analysis.+Br+J+Anaesth.+2012%3B110(2)%3A191%E2%80%93200.</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=Kakodkar+PS.+Routine+use+of+dexamethasone+for+postoperative+nausea+and+vomiting%3A+the+case+for.+Anaesthesia.+2013+Sep%3B68(9)%3A889%E2%80%9391.</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=Standards+of+Medical+Care+in+Diabetes%E2%80%942016%3A+Summary+of+Revisions.+Diabetes+Care.+2016+Jan+1%3B39</url>
    <description>Related Info</description>
  </link>
  <reference>
    <citation>Wenk M, Schug SA. Perioperative pain management after thoracotomy. Curr Opin Anaesthesiol. 2011 Feb;24(1):8-12. doi: 10.1097/ACO.0b013e3283414175. Review.</citation>
    <PMID>21084984</PMID>
  </reference>
  <reference>
    <citation>Doan LV, Augustus J, Androphy R, Schechter D, Gharibo C. Mitigating the impact of acute and chronic post-thoracotomy pain. J Cardiothorac Vasc Anesth. 2014 Aug;28(4):1048-56. doi: 10.1053/j.jvca.2014.02.021. Review.</citation>
    <PMID>25107721</PMID>
  </reference>
  <reference>
    <citation>Henzi I, Walder B, TramÃ¨r MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2000 Jan;90(1):186-94.</citation>
    <PMID>10625002</PMID>
  </reference>
  <reference>
    <citation>Waldron NH, Jones CA, Gan TJ, Allen TK, Habib AS. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis. Br J Anaesth. 2013 Feb;110(2):191-200. doi: 10.1093/bja/aes431. Epub 2012 Dec 5. Review.</citation>
    <PMID>23220857</PMID>
  </reference>
  <reference>
    <citation>Kakodkar PS. Routine use of dexamethasone for postoperative nausea and vomiting: the case for. Anaesthesia. 2013 Sep;68(9):889-91. doi: 10.1111/anae.12308. Epub 2013 Jul 15.</citation>
    <PMID>23848292</PMID>
  </reference>
  <reference>
    <citation>Standards of Medical Care in Diabetes-2016: Summary of Revisions. Diabetes Care. 2016 Jan;39 Suppl 1:S4-5. doi: 10.2337/dc16-S003. Review.</citation>
    <PMID>26696680</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 14, 2020</study_first_submitted>
  <study_first_submitted_qc>March 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2020</study_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Trieste</investigator_affiliation>
    <investigator_full_name>Marzia Umari</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Thoracic surgery</keyword>
  <keyword>Postoperative complications</keyword>
  <keyword>Dexamethasone</keyword>
  <keyword>Postoperative Nausea and Vomiting</keyword>
  <keyword>Hyperglycaemia</keyword>
  <keyword>Video Assisted ThoracoScopy (VATS)</keyword>
  <keyword>Multimodal Analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

